ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.
ICU Medical made more money than expected last quarter and promised even better results ahead, so stock experts think the company is doing really well. When a company beats expectations and raises its goals, it's usually a sign that the business is running smoothly and people feel more confident about it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.